Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mild vs Conventional Ovarian Stimulation in IVF
NCT00866008Phase 4Terminated
- Start
- Oct 2008
- Primary completion
- Jan 2011
- Modality
- rProtein (Recombinant Protein), Hormone, Biologic
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of recombinant human chorionic gonadotrophin in infertility (2 arms). Primary endpoint: Proportion of chromosomally abnormal and mosaic day 3 embryos per patient at 2 years. Started Oct 2008; status: terminated.
02
Drugs
recombinant human chorionic gonadotrophin
03
Conditions
infertility
Beyond the preview
Go deeper on NCT00866008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00866008.